NCT03194867 · Interventional trial
Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Overall registry status Completed
Phase 1 · Phase 2
Conditions Plasma Cell Myeloma
Delaware Valley sites
- Fox Chase Cancer Center-Site Number:8400004 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory